[{"id":"48d1c422-cd06-4d80-878d-98ad6d3840e7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03664635","created_at":"2021-01-18T17:58:55.471Z","updated_at":"2024-07-02T16:35:08.135Z","phase":"Phase 1/2","brief_title":"MB-CART20.1 Lymphoma","source_id_and_acronym":"NCT03664635","lead_sponsor":"Miltenyi Biomedicine GmbH","biomarkers":" CD20","pipe":"","alterations":" ","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MB-CART20.1"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 19","initiation":"Initiation: 09/25/2018","start_date":" 09/25/2018","primary_txt":" Primary completion: 09/30/2024","primary_completion_date":" 09/30/2024","study_txt":" Completion: 09/30/2024","study_completion_date":" 09/30/2024","last_update_posted":"2024-04-23"}]